---
phase: 02-dossier-batch
plan: "06"
subsystem: global-library
tags: [end-of-batch, reporting, structured-coverage, taxonomy, source-capture, botox, neurotoxins]
dependency_graph:
  requires:
    - 02-03 (HA filler compile results)
    - 02-04 (biostimulator + body contouring compile results)
    - 02-05 (energy device + remaining product compile results)
  provides:
    - STRUCTURED_COVERAGE.md (per-product structured intelligence coverage)
    - TAXONOMY_ADDITIONS.md (all taxonomy additions for Chris review)
    - SOURCE_CAPTURE_REPORT.md (93 ingestion_queue entries, top 10 OA Botox/Neurotoxin papers)
    - compile_manifest.json with batch_status=complete
  affects:
    - Chris's pre-demo review workflow
    - Post-demo ingestion queue priority ordering
    - SQL execution checklist (12 products pending DB push)
tech_stack:
  added: []
  patterns:
    - Live Supabase query for DB state validation (item_concerns, item_body_areas, evidence_links)
    - Cross-reference compile_manifest.json with live DB to identify SQL-written-not-executed gap
key_files:
  created:
    - .planning/phases/02-dossier-batch/STRUCTURED_COVERAGE.md
    - .planning/phases/02-dossier-batch/TAXONOMY_ADDITIONS.md
    - .planning/phases/02-dossier-batch/SOURCE_CAPTURE_REPORT.md
  modified:
    - compile_manifest.json (batch_status=complete, reports_generated, batch_summary)
decisions:
  - "Live DB shows 02-03 SQL executed (5 HA fillers in DB), 02-04 partial (Sculptra/Kybella structured emission present, CoolSculpting 0), 02-05 not executed (all 9 products show 0 docs and 0 concerns in live DB)"
  - "Dysport shows 8 item_concerns + 12 body_areas in live DB from earlier Dysport-specific execution (predates 02-05 batch run)"
  - "SKINVIVE zero zone-level anatomy accepted as intentional — intradermal cheek hydrator does not warrant anatomical subzone mapping"
  - "FDA validation PASS — 0 orphaned FDA-indicated concerns across all 12 live FDA-indicated rows"
  - "Top 10 OA paper list for Botox/Neurotoxins fast-track led by ASJ Open Forum + Dermatology and Therapy (CC-BY-NC) which have 10 directly relevant neurotoxin comparison studies"
metrics:
  duration: "8 minutes"
  completed: "2026-06-12"
  tasks_completed: 2
  tasks_total: 2
  files_created: 3
  files_modified: 1
---

# Phase 02 Plan 06: End-of-Batch Reports Summary

**One-liner:** Three batch validation reports generated from live Supabase queries: STRUCTURED_COVERAGE (FDA validation PASS, 9 products pending SQL execution), TAXONOMY_ADDITIONS (7 new concerns, 3 new body areas, ~124 aliases for Chris review), SOURCE_CAPTURE_REPORT (93 ingestion_queue entries, top 10 OA Botox/Neurotoxin papers flagged for immediate pre-demo ingestion).

## What Was Done

### Task 1: STRUCTURED_COVERAGE.md + TAXONOMY_ADDITIONS.md

**Coverage report methodology:** Queried live Supabase DB (aejskvmpembryunnbgrk) directly for item_concerns, item_body_areas (with anatomy_specificity), agent_reference_docs, and does_not_solve for all 19 batch products.

**Key finding:** 02-05 SQL files were committed to `supabase/compile_sql/` but not executed against the live DB. Energy devices (Morpheus8, Sofwave, Ultherapy, Hollywood Spectra), most neurotoxins (Jeuveau, Daxxify, Xeomin), and HydraFacial Syndeo all show 0 rows for item_concerns, item_body_areas, and agent_reference_docs. CoolSculpting Elite also shows 0 item_concerns/body_areas (02-04-task2 SQL not executed). This is documented accurately in STRUCTURED_COVERAGE.md rather than assumed complete.

**FDA validation result:** 0 orphaned FDA-indicated concerns. All 12 is_fda_indicated=true rows have corresponding evidence_links rows with source='fda_label'. PASS.

**Taxonomy additions:** 7 new concerns (Age-Related Volume Loss, Skin Hydration, Skin Quality Improvement, Chin Augmentation, Lip Augmentation, Dynamic Wrinkle Correction, Buttock Augmentation), 3 new body areas (Midface, Chin Projection Zone, Dorsal Hand), ~124 aliases.

### Task 2: SOURCE_CAPTURE_REPORT.md + compile_manifest.json update

**Source registry state:** 50 total entries. 38 added during Phase 02 batch (added_by='discovery'). Breakdown: 15 authority_rank=1 regulatory/FDA sources (all public domain), 19 authority_rank=2 journals (mixed rights), 4 rank=3 journals, 12 pre-existing seed entries.

**Ingestion queue:** 93 total entries. The bulk (65+) came from a journal_scout_2026_06_12 run that captured ASJ Open Forum, Cureus, Dermatology and Therapy, Journal of Cosmetic Dermatology, and Dermatologic Surgery articles — all OA or CC-BY-NC.

**Top 10 OA papers for Botox/Neurotoxins fast-track:** All 10 have confirmed PMC URLs and OA rights class. Priority journals represented:
- ASJ Open Forum (2 papers — Botulinum+Laser combination, AbobotulinumtoxinA parameters)
- Dermatology and Therapy (7 papers — head-to-head comparisons, diffusion, micro-dosing, duration, antibody resistance, Xeomin efficacy)
- Cureus (1 paper — ophthalmic complications/safety review)

**compile_manifest.json:** Updated with batch_status="complete", reports_generated array, and batch_summary including taxonomy additions count, FDA validation result, and pending_action note.

## Structured Intelligence Coverage Summary (Live DB)

| Product | item_concerns | item_body_areas | Zone-level | does_not_solve | Docs |
|---------|:---:|:---:|:---:|:---:|:---:|
| Botox Cosmetic | 10 | 12 | 11 | 8 entries | 5 |
| Juvederm Voluma XC | 8 | 7 | 3 | 7 entries | 5 |
| Juvederm Vollure XC | 5 | 5 | 2 | 6 entries | 5 |
| SKINVIVE by Juvederm | 5 | 2 | 0* | 7 entries | 5 |
| Restylane Lyft | 7 | 7 | 3 | 6 entries | 5 |
| RHA Redensity | 4 | 4 | 2 | 7 entries | 5 |
| Sculptra Aesthetic | 5 | 14 | 4 | NULL** | 0** |
| Kybella | 1 | 1 | 1 | NULL** | 0** |
| Dysport | 8 | 12 | 11 | NULL** | 0** |
| 9 remaining products | 0 | 0 | 0 | NULL** | 0** |

*Intentional — SKINVIVE is a cheek-only intradermal product.
**SQL written and committed but not yet executed in live DB.

## Deviations from Plan

### Auto-fixed Issues

**1. [Rule 2 - Completeness] STRUCTURED_COVERAGE built from live DB queries rather than SQL execution**
- **Found during:** Task 1 pre-execution
- **Issue:** Plan specified running SQL verification queries; context note warned "some energy device and remaining product data may not yet be in the live DB." Live DB queries confirmed this exactly — 02-05 SQL not executed.
- **Fix:** Report accurately documents live DB state vs SQL-written-not-executed state. Report provides a priority-ordered execution checklist rather than assuming completeness. This is more useful to Chris than a report that inaccurately claims coverage.
- **Files modified:** STRUCTURED_COVERAGE.md accurately reflects gap

**2. [Rule 1 - Bug] compile_manifest.json agent_reference_docs counts discrepancy**
- **Found during:** Task 1 DB validation
- **Issue:** compile_manifest.json and plan 02-04 SUMMARY claim 15 agent_reference_docs for Sculptra/Kybella/CoolSculpting. Live DB query for status='draft' by offering_id returns 0 for these products.
- **Fix:** Both states documented in STRUCTURED_COVERAGE. The SQL files exist and are committed — the discrepancy is execution, not data quality. No data correction needed; the SQL is correct.
- **No commit needed:** Documentation-only fix, captured in report.

## Known Stubs

None — all three report files contain substantive data from live Supabase queries. No placeholder text. The STRUCTURED_COVERAGE accurately captures which products have data and which don't, rather than approximating from plan summaries.

## Self-Check: PASSED

- [x] STRUCTURED_COVERAGE.md created — EXISTS
- [x] TAXONOMY_ADDITIONS.md created — EXISTS
- [x] SOURCE_CAPTURE_REPORT.md created — EXISTS
- [x] SOURCE_CAPTURE_REPORT contains "INGEST IMMEDIATELY" for each of 10 OA papers — CONFIRMED (grep count: 10)
- [x] FDA validation result: 0 orphaned — CONFIRMED via live DB query
- [x] compile_manifest.json updated with batch_status=complete — CONFIRMED
- [x] Commit 1fca4a7 (Task 1 — STRUCTURED_COVERAGE + TAXONOMY_ADDITIONS) — EXISTS
- [x] Commit 45c0194 (Task 2 — SOURCE_CAPTURE_REPORT + compile_manifest) — EXISTS
- [x] Top 10 OA papers all from priority journals (ASJ, Dermatology and Therapy, Cureus) — CONFIRMED
- [x] No PHI in any report file — CONFIRMED (all content is product/journal/regulatory data)
